Evolution of immunotherapy in the treatment of non-muscle-invasive bladder cancer-Reference-Cited by-同舟云学术

Evolution of immunotherapy in the treatment of non-muscle-invasive bladder cancer

Published:2022-03-01 Issue:4 Volume:22 Page:361-370
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Lobo Niyati¹^ORCID,Martini Alberto²,Kamat Ashish M.¹

Affiliation:

1. Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

2. Department of Urology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy

Funder

the Wayne B. Duddlesten Professorship in Cancer Research and the Raymond and Maria Floyd Bladder Cancer Research Foundation to AM Kamat and the Urology Foundation-Fulbright Scholar Award to N Lobo

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2022.2046466

Reference91 articles.

1. CONTRIBUTION TO THE KNOWLEDGE OF SARCOMA

2. Proceedings: Some aspects of the use of B.C.G. in the treatment of advanced malignant disease

3. Methotrexate plus bacillus Calmette-Guérin (BCG) and isoniazid in the treatment of cancer of the head and neck

4. Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors

5. Bacillus Calmette-guerin Immunotherapy of Superficial Bladder Cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Strategies for BCG Unresponsive Non-muscle Invasive Bladder Cancer;annals of urologic oncology;2024-08-29

2. OncoTherad® (MRB-CFI-1) Nanoimmunotherapy: A Promising Strategy to Treat Bacillus Calmette–Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer: Crosstalk among T-Cell CX3CR1, Immune Checkpoints, and the Toll-Like Receptor 4 Signaling Pathway;International Journal of Molecular Sciences;2023-12-15

3. Immune Activation Profiles Elicited by Distinct, Repeated TLR Agonist Infusions in Rhesus Macaques;The Journal of Immunology;2023-10-20

4. Optimizing Boron Neutron Capture Therapy (BNCT) to Treat Cancer: An Updated Review on the Latest Developments on Boron Compounds and Strategies;Cancers;2023-08-14

5. Epigenetic m6A RNA Modification Reader YTHDF1 in Merkel Cell Carcinoma;Cancers;2023-08-12